Hepatitis C infection and intrahepatic cholestasis of pregnancy: A systematic review and meta-analysis

Clinics and Research in Hepatology and Gastroenterology

Volumn 41, Issue 1, 2017, Pages 39-45

  Wijarnpreecha, Karn ^a   Thongprayoon, Charat ^a   Sanguankeo, Anawin ^a,b   Upala, Sikarin ^a,b   Ungprasert, Patompong ^b,c   Cheungpasitporn, Wisit ^c  

^a BASSETT MEDICAL CENTER   (United States)

^b MAHIDOL UNIVERSITY   (Thailand)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONFIDENCE INTERVAL; FEMALE; HAZARD RATIO; HEPATITIS C; HUMAN; INTRAHEPATIC CHOLESTASIS; OBSERVATIONAL STUDY; PREGNANCY; PREGNANT WOMAN; QUALITY CONTROL; RISK FACTOR; VARIANCE; COMPLICATION; DIFFERENTIAL DIAGNOSIS; MASS SCREENING; META ANALYSIS; PREGNANCY COMPLICATION; VIROLOGY;

CHOLESTASIS, INTRAHEPATIC; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEPATITIS C; HUMANS; MASS SCREENING; OBSERVATIONAL STUDIES AS TOPIC; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK FACTORS;

EID: 84995468849     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2016.07.004     Document Type: Article

References (30)

1. [1] Mohd Hanafiah, K., Groeger, J., Flaxman, A.D., Wiersma, S.T., Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 57:4 (2013), 1333–1342.
2. [2] Udompap, P., Mannalithara, A., Heo, N.Y., Kim, D., Kim, W.R., Increasing prevalence of cirrhosis among U.S. adults aware or unaware of their chronic hepatitis C virus infection. J Hepatol 64:5 (2016), 1027–1032.
3. [3] Conte, D., Fraquelli, M., Prati, D., Colucci, A., Minola, E., Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women. Hepatology 31:3 (2000), 751–755.
4. [4] Floreani, A., Hepatitis C and pregnancy. World J Gastroenterol 19:40 (2013), 6714–6720.
5. [5] Ohto, H., Ishii, T., Kitazawa, J., Sugiyama, S., Ujiie, N., Fujimori, K., et al. Declining hepatitis C virus (HCV) prevalence in pregnant women: impact of anti-HCV screening of donated blood. Transfusion (Paris) 50:3 (2010), 693–700.
6. [6] Ward, C., Tudor-Williams, G., Cotzias, T., Hargreaves, S., Regan, L., Foster, G.R., Prevalence of hepatitis C among pregnant women attending an inner London obstetric department: uptake and acceptability of named antenatal testing. Gut 47:2 (2000), 277–280.
7. [7] Floreani, A., Paternoster, D., Zappala, F., Cusinato, R., Bombi, G., Grella, P., et al. Hepatitis C virus infection in pregnancy. Br J Obstet Gynaecol 103:4 (1996), 325–329.
8. [8] Granovsky, M.O., Minkoff, H.L., Tess, B.H., Waters, D., Hatzakis, A., Devoid, D.E., et al. Hepatitis C virus infection in the mothers and infants cohort study. Pediatrics 102:2 Pt 1 (1998), 355–359.
9. [9] Jabeen, T., Cannon, B., Hogan, J., Crowley, M., Devereux, C., Fanning, L., et al. Pregnancy and pregnancy outcome in hepatitis C type 1b. QJM 93:9 (2000), 597–601.
10. [10] Locatelli, A., Roncaglia, N., Arreghini, A., Bellini, P., Vergani, P., Ghidini, A., Hepatitis C virus infection is associated with a higher incidence of cholestasis of pregnancy. Br J Obstet Gynaecol 106:5 (1999), 498–500.
11. [11] Marschall, H.U., Wikstrom Shemer, E., Ludvigsson, J.F., Stephansson, O., Intrahepatic cholestasis of pregnancy and associated hepatobiliary disease: a population-based cohort study. Hepatology 58:4 (2013), 1385–1391.
12. [12] Paternoster, D.M., Fabris, F., Palu, G., Santarossa, C., Bracciante, R., Snijders, D., et al. Intra-hepatic cholestasis of pregnancy in hepatitis C virus infection. Acta Obstet Gynecol Scand 81:2 (2002), 99–103.
13. [13] Ropponen, A., Sund, R., Riikonen, S., Ylikorkala, O., Aittomaki, K., Intrahepatic cholestasis of pregnancy as an indicator of liver and biliary diseases: a population-based study. Hepatology 43:4 (2006), 723–728.
14. [14] Floreani, A., Gervasi, M.T., New insights on intrahepatic cholestasis of pregnancy. Clin Liver Dis 20:1 (2016), 177–189.
15. [15] Joshi, D., James, A., Quaglia, A., Westbrook, R.H., Heneghan, M.A., Liver disease in pregnancy. Lancet 375:9714 (2010), 594–605.
16. [16] Belay, T., Woldegiorgis, H., Gress, T., Rayyan, Y., Intrahepatic cholestasis of pregnancy with concomitant hepatitis C virus infection, Joan C. Edwards SOM, Marshall University. Eur J Gastroenterol Hepatol 27:4 (2015), 372–374.
17. [17] Berkley, E.M., Leslie, K.K., Arora, S., Qualls, C., Dunkelberg, J.C., Chronic hepatitis C in pregnancy. Obstet Gynecol 112:2 Pt 1 (2008), 304–310.
18. [18] Reddick, K.L., Jhaveri, R., Gandhi, M., James, A.H., Swamy, G.K., Pregnancy outcomes associated with viral hepatitis. J Viral Hepat 18:7 (2011), e394–e398.
19. [19] Stang, A., Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:9 (2010), 603–605.
20. [20] Herzog, R., Alvarez-Pasquin, M.J., Diaz, C., Del Barrio, J.L., Estrada, J.M., Gil, A., Are healthcare workers’ intentions to vaccinate related to their knowledge, beliefs and attitudes? A systematic review. BMC Public Health, 13, 2013, 154.
21. [21] DerSimonian, R., Laird, N., Meta-analysis in clinical trials. Control Clin Trials 7:3 (1986), 177–188.
22. [22] Higgins, J.P., Thompson, S.G., Deeks, J.J., Altman, D.G., Measuring inconsistency in meta-analyses. BMJ 327:7414 (2003), 557–560.
23. [23] Hinoshita, E., Taguchi, K., Inokuchi, A., Uchiumi, T., Kinukawa, N., Shimada, M., et al. Decreased expression of an ATP-binding cassette transporter, MRP2, in human livers with hepatitis C virus infection. J Hepatol 35:6 (2001), 765–773.
24. [24] Beuers, U., Pusl, T., Intrahepatic cholestasis of pregnancy—a heterogeneous group of pregnancy-related disorders?. Hepatology 43:4 (2006), 647–649.
25. [25] Marin, J.J., Macias, R.I., Briz, O., Banales, J.M., Monte, M.J., Bile acids in physiology, pathology and pharmacology. Curr Drug Metab 17:1 (2015), 4–29.
26. [26] Yan, H., Zhong, G., Xu, G., He, W., Jing, Z., Gao, Z., et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. eLife, 3, 2014.
27. [27] Hanada, K., Nakai, K., Tanaka, H., Suzuki, F., Kumada, H., Ohno, Y., et al. Effect of nuclear receptor downregulation on hepatic expression of cytochrome P450 and transporters in chronic hepatitis C in association with fibrosis development. Drug Metab Pharmacokinet 27:3 (2012), 301–306.
28. [28] Goodman, Z.D., Ishak, K.G., Histopathology of hepatitis C virus infection. Semin Liver Dis 15:1 (1995), 70–81.
29. [29] Iwata, R., Baur, K., Stieger, B., Mertens, J.C., Daly, A.K., Frei, P., et al. A common polymorphism in the ABCB11 gene is associated with advanced fibrosis in hepatitis C but not in non-alcoholic fatty liver disease. Clin Sci (Lond) 120:7 (2011), 287–296.
30. [30] Dixon, P.H., van Mil, S.W., Chambers, J., Strautnieks, S., Thompson, R.J., Lammert, F., et al. Contribution of variant alleles of ABCB11 to susceptibility to intrahepatic cholestasis of pregnancy. Gut 58:4 (2009), 537–544.